<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04941053</url>
  </required_header>
  <id_info>
    <org_study_id>Soh-Med-21-04-33</org_study_id>
    <nct_id>NCT04941053</nct_id>
  </id_info>
  <brief_title>Seroprevalence of COVID-19</brief_title>
  <acronym>cov prevalence</acronym>
  <official_title>Seroprevalence of COVID19 in Sohag Governorate Egypt</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Coronavirus disease pandemic has been started in late 2019. Since this date, the number of&#xD;
      cases has been increased reaching 32.7 million cases worldwide in 27 September, 2020. . Herd&#xD;
      immunity is achieved when enough people become immune to a virus to stop its spread. Around&#xD;
      70% to 90% of a population needs to be immune to protect the uninfected. In A Spanish study&#xD;
      of more than 30,000 people estimates that around just 5% of the Spanish population has&#xD;
      developed antibodies&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aims of work:&#xD;
&#xD;
      A cross-sectional study to detect the seroprevalence to COVID 19 in chronic hemodialysis&#xD;
      patients and compare it with the COVID 19 seroprevalence in healthy control in Sohag&#xD;
      governorate Egypt&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      After taken informed consent according to Sohag University Ethical Committee A questionnaire&#xD;
      on coronavirus symptoms will be asked including epidemiological characters and history of&#xD;
      previous COVID 19 infection and infection control measures to prevent it&#xD;
&#xD;
      5 ml of the blood sample will be taken for IgG antibodies testing with a chemiluminescent&#xD;
      microparticle immunoassay.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 3, 2021</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>seroprevalnce</measure>
    <time_frame>3-6-2021 to 30-8-2021</time_frame>
    <description>antibody measurement</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>group 1 chronic haemodialysis patients</arm_group_label>
    <description>seroprevalnce of COVID 19</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy control</arm_group_label>
    <description>seroprevalnce of COVID 19</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>laboratory test</intervention_name>
    <description>seroprevalnce</description>
    <arm_group_label>group 1 chronic haemodialysis patients</arm_group_label>
    <arm_group_label>healthy control</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum sample&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        group 1 patients coming to hemodialysis unit group 2 relative to patients coming to&#xD;
        hemodialysis unit, medical staff&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient accept to participate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  vaccinated people&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>N S shafik, lecturer</last_name>
    <role>Principal Investigator</role>
    <affiliation>sohag university hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>N S Shafik, lecturer</last_name>
    <phone>02 01067261504</phone>
    <phone_ext>02</phone_ext>
    <email>Nohasaber@med.sohag.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>M M Abd El Rhman, lecturer</last_name>
    <phone>01021025859</phone>
    <phone_ext>02</phone_ext>
    <email>monamohamed@med.sohag.edu.eg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sohag University</name>
      <address>
        <city>Sohag</city>
        <zip>82733</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>N S Shafik, lecture</last_name>
      <phone>01067261504</phone>
      <phone_ext>02</phone_ext>
      <email>nohasaber@med.sohag.edu.eg</email>
    </contact>
    <contact_backup>
      <last_name>M M Abd El Rhman, lecturer</last_name>
      <phone>01021025859</phone>
      <phone_ext>02</phone_ext>
      <email>monamohamed@med.sohag.edu.eg</email>
    </contact_backup>
    <investigator>
      <last_name>S B Hemdan, lecturer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>R M Farag, lecturer</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>A N Elsayed, lecturer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 23, 2021</study_first_submitted>
  <study_first_submitted_qc>June 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 28, 2021</study_first_posted>
  <last_update_submitted>June 26, 2021</last_update_submitted>
  <last_update_submitted_qc>June 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Noha Saber Shafik</investigator_full_name>
    <investigator_title>lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>to protect privacy of data of patients</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

